The Safety And Efficacy Evaluation Of Recombinant Human Collagen Vaginal Gel For The Treatment Of Vaginal Dryness

Trial Profile

The Safety And Efficacy Evaluation Of Recombinant Human Collagen Vaginal Gel For The Treatment Of Vaginal Dryness

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2016

At a glance

  • Drugs Recombinant collagen (Primary) ; Hyaluronic acid
  • Indications Atrophic vaginitis; Vaginal diseases
  • Focus Therapeutic Use
  • Sponsors Shanxi Jinbo Bio-Pharmaceutical
  • Most Recent Events

    • 02 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top